The trademark application mini-Gut was filed by Novoheart International Limited, a corporation established under the laws of Hong Kong, Special Administrative Region of the People's Republic of China (the "Applicant"). Application refused.
The application was filed in English (Spanish was selected as the second language).
The Refusal with reference B 018751129 was Rejected according to Article 7(1)(b) EUTMR with decision issued on March 13, 2023 by the EUIPO.
Goods And Services
The mark was filed in class 42 with following description of goods:
Bacteriological research
Biological research
Biomedical research services
Biotechnology research
Chemical research
Conducting clinical trials
Conducting clinical trials for others [scientific research]
Conducting early evaluations in the field of new pharmaceuticals
Development of biopharmaceutical products and medicine
Drug discovery services
Engineering services, particularly technical project planning and design engineering of lines for the processing of web products
Industrial research in the field of biotechnology
Industrial research in the field of regenerative and reparative therapies
Industrial research services
Medical and pharmaceutical research services
Medical laboratory services
Medical research
Pharmaceutical and biotechnology research services
Pharmaceutical drug development services
Product evaluation and analysis
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Research and development and consultation related thereto in the field of technique
Research and development of new products for others
Research and development of vaccines and medicines
Scientific and technology services, namely, research and design in the field of science and technology
Scientific laboratory services
Scientific research
Scientific research and development
Scientific research in the field of gene therapy
Stem cell research services
Technical research
Technical research in the field of pharmaceutical studies
Technology research in the field of regenerative and reparative therapies.